Jaan Biotherapeutics LLC

JBT is developing a therapy for ischemic heart disease involving the regeneration of cardiac muscle by inhibiting miRs suppressed in the evolution process.

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, US
  • Currency USD
  • Founded February 2015
  • Employees 6
  • Incorporation Type LLC
  • Website jaanbio.com

Company Summary

JBT's is developing a cardiac muscle regeneration therapy currently focused on ischemic heart disease. The therapy, based on a Salk institute patent with UCSD confirming studies, inhibits 4 miRs to activate the endogenous cardiac muscle regeneration process suppressed in adult humans in the evolution process. Notice of a NIH grant award was also recently received.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free